2 days Amgen (NASDAQ:AMGN) Downgraded by Truist Financial to HoldMarketBeat
Truist Financial downgraded Amgen from a “buy” rating to a “hold” rating and increased their price target for the stock from $320.00 to $333.00 in a research report on Monday.
Amgen (AMGN) · Nasdaq 100 · Science · Truist Financial Corp (TFC)
X